Skip to main content
UniHealth

Doctor search

Christina Suzan Kong, MD

Pathology · Stanford

NPI 1538212337

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kong’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G77567 · Current

Licensed to practise in California · since 1993 · expires 2027-07-31 · University of California San Francisco School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$61,007

Medicare paid this office $61,007 for 831 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Cell examination of specimen, selective cellular enhancement technique581$15,425$24
Pathology examination of tissue using a microscope, intermediate complexity270$11,930$33
Evaluation of fine needle aspirate with interpretation and report101$10,139$62
Special stained specimen slides to examine tissue, each additional procedure68$5,925$25
Surgical pathology consultation and report on referred slides prepared elsewhere41$3,076$75
See all 15 services
Every Original Medicare service billed
Cell examination of specimen, selective cellular enhancement technique581$15,425$24
Pathology examination of tissue using a microscope, intermediate complexity270$11,930$33
Evaluation of fine needle aspirate with interpretation and report101$10,139$62
Special stained specimen slides to examine tissue, each additional procedure68$5,925$25
Surgical pathology consultation and report on referred slides prepared elsewhere41$3,076$75
Special stained specimen slides to examine tissue, initial procedure77$2,450$31
Evaluation of fine needle aspirate60$2,104$31
Microscopic genetic analysis of tumor, manual29$1,712$37
Cell examination of specimen, concentration technique54$1,112$20
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure11$1,019$57
Pathology cytologic examination of specimen during surgery, initial site15$1,000$56
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode27$768$18
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician25$765$31
Genetic sequencing localization, initial procedure13$500$38
Pap test15$342$23

Who their Medicare patients are

831 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 50% · Also on Medicaid 22% · Health risk score 1.89. Above the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 75% · Cancer 42% · Chronic kidney disease 35% · Diabetes 34% · Coronary heart disease 34% · Atrial fibrillation 23% · Heart failure 20% · Depression 20% · COPD 18% · Stroke 13% · Dementia 10%.

The office billed $868,877, Medicare allowed $78,012 and paid $61,007; for 1,901 services of 31 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20248311,901751.89$868,877$61,007
20238462,304742.08$851,151$80,260
20227262,440741.74$783,538$88,192
20216102,045741.65$587,893$80,746
20204981,389741.77$368,410$53,356
20197852,340731.84$661,272$92,462
20187661,973721.87$522,589$80,652
20176702,022731.70$520,196$83,765
20164791,411721.67$350,632$56,057
20157102,169711.77$529,345$87,978
20147522,247711.59$502,715$86,538
20139022,461711.47$538,749$111,480

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 16 services

Original Medicare services billed in 2023
Evaluation of fine needle aspirate with interpretation and report173$16,943$65
Pathology examination of tissue using a microscope, intermediate complexity317$15,564$34
Cell examination of specimen, selective cellular enhancement technique510$14,715$25
Special stained specimen slides to examine tissue, each additional procedure91$9,574$26
Evaluation of fine needle aspirate126$4,534$33
Special stained specimen slides to examine tissue, initial procedure108$3,635$32
Surgical pathology consultation and report on referred slides prepared elsewhere41$3,117$76
Microscopic genetic analysis of tumor, manual39$2,872$39
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode57$1,665$20
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure11$996$59
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician27$796$29
Fine needle aspiration biopsy using ultrasound guidance, first growth11$732$67
Special stained specimen slides to identify organisms including interpretation and report13$666$25
Cell examination of specimen, concentration technique32$654$19
Genetic sequencing localization, initial procedure14$641$40
Fine needle aspiration biopsy, first growth12$600$50

2022: 19 services

Original Medicare services billed in 2022
Evaluation of fine needle aspirate with interpretation and report229$21,313$65
Pathology examination of tissue using a microscope, intermediate complexity327$18,219$35
Special stained specimen slides to examine tissue, each additional procedure105$8,723$26
Cell examination of specimen, selective cellular enhancement technique280$7,470$25
Evaluation of fine needle aspirate143$6,112$33
Special stained specimen slides to examine tissue, initial procedure125$4,487$32
Surgical pathology consultation and report on referred slides prepared elsewhere44$3,050$69
Microscopic genetic analysis of tumor, manual43$2,799$39
Pathology examination of tissue using a microscope, moderately high complexity22$2,402$75
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure18$1,816$59
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode48$1,671$20
Special stained specimen slides to identify organisms including interpretation and report21$1,365$24
Flow cytometry technique for dna or cell analysis, 16 or more markers16$1,166$73
Special stained specimen slides to examine tissue including interpretation and report35$986$11
Fine needle aspiration biopsy, first growth14$650$46
Genetic sequencing localization, initial procedure15$611$41
Pathology examination of tissue using a microscope, moderately low complexity42$485$10
Preparation of tissue for examination by removing any calcium present22$328$11
Cell examination of specimen, concentration technique11$232$21

2021: 18 services

Original Medicare services billed in 2021
Evaluation of fine needle aspirate with interpretation and report206$20,301$66
Pathology examination of tissue using a microscope, intermediate complexity244$12,504$35
Special stained specimen slides to examine tissue, each additional procedure92$9,959$27
Cell examination of specimen, selective cellular enhancement technique264$7,220$26
Surgical pathology consultation and report on referred slides prepared elsewhere85$6,722$79
Evaluation of fine needle aspirate152$6,669$34
Special stained specimen slides to examine tissue, initial procedure108$3,915$33
Microscopic genetic analysis of tumor, manual47$3,164$40
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure12$1,206$60
Flow cytometry technique for dna or cell analysis, 16 or more markers15$1,136$76
Fine needle aspiration biopsy, first growth21$1,064$51
Pathology cytologic examination of specimen during surgery, initial site17$1,013$60
Genetic sequencing localization, initial procedure23$955$42
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode34$857$20
Fine needle aspiration biopsy using ultrasound guidance, first growth13$797$61
Special stained specimen slides to identify organisms including interpretation and report17$787$25
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening13$415$32
Cell examination of specimen, concentration technique13$280$22

2020: 9 services

Original Medicare services billed in 2020
Evaluation of fine needle aspirate with interpretation and report152$12,872$69
Pathology examination of tissue using a microscope, intermediate complexity193$8,407$37
Special stained specimen slides to examine tissue, each additional procedure79$8,075$27
Cell examination of specimen, selective cellular enhancement technique255$6,234$23
Surgical pathology consultation and report on referred slides prepared elsewhere50$4,023$80
Special stained specimen slides to examine tissue, initial procedure96$3,462$35
Microscopic genetic analysis of tumor, manual40$2,400$41
Evaluation of fine needle aspirate56$2,083$35
Special stained specimen slides to identify organisms including interpretation and report16$885$26

2019: 19 services

Original Medicare services billed in 2019
Evaluation of fine needle aspirate with interpretation and report274$22,925$67
Pathology examination of tissue using a microscope, intermediate complexity319$13,827$36
Special stained specimen slides to examine tissue, each additional procedure137$12,219$28
Cell examination of specimen, selective cellular enhancement technique331$9,252$25
Surgical pathology consultation and report on referred slides prepared elsewhere84$6,563$77
Special stained specimen slides to examine tissue, initial procedure171$6,277$34
Microscopic genetic analysis of tumor, manual63$3,937$41
Evaluation of fine needle aspirate105$3,847$34
Fine needle aspiration biopsy using ultrasound guidance, first growth26$1,660$61
Special stained specimen slides to identify organisms including interpretation and report37$1,373$25
Surgical pathology consultation and report on referred material requiring preparation of slides15$1,248$83
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure13$1,215$61
Flow cytometry technique for dna or cell analysis, 9 to 15 markers20$1,201$60
Pathology cytologic examination of specimen during surgery, initial site13$787$61
Genetic sequencing localization, initial procedure17$754$42
Fine needle aspiration biopsy, first growth13$658$51
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening15$470$31
Special stained specimen slides to examine tissue including interpretation and report23$373$11
Cell examination of specimen, concentration technique16$323$20

2018: 19 services

Original Medicare services billed in 2018
Evaluation of fine needle aspirate with interpretation and report219$18,386$67
Pathology examination of tissue using a microscope, intermediate complexity255$11,165$36
Cell examination of specimen, selective cellular enhancement technique320$9,313$26
Special stained specimen slides to examine tissue, each additional procedure93$8,313$27
Surgical pathology consultation and report on referred slides prepared elsewhere93$7,424$78
Special stained specimen slides to examine tissue, initial procedure118$4,502$34
Evaluation of fine needle aspirate95$3,578$34
Pathology examination of tissue using a microscope, moderately high complexity30$3,398$79
Fine needle aspiration biopsy, first growth33$2,098$60
Microscopic genetic analysis of tumor, manual35$1,876$43
Surgical pathology consultation and report on referred material requiring preparation of slides18$1,481$82
Special stained specimen slides to identify organisms including interpretation and report35$1,321$25
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure12$1,316$60
Fine needle aspiration using imaging guidance15$996$59
Genetic sequencing localization, initial procedure12$546$42
Cell examination of specimen, concentration technique24$536$21
Ultrasonic guidance for needle placement15$438$29
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening13$407$31
Special stained specimen slides to examine tissue including interpretation and report22$372$11

2017: 20 services

Original Medicare services billed in 2017
Evaluation of fine needle aspirate with interpretation and report227$19,302$66
Pathology examination of tissue using a microscope, intermediate complexity266$12,266$36
Special stained specimen slides to examine tissue, each additional procedure101$9,272$27
Cell examination of specimen, selective cellular enhancement technique272$7,802$25
Surgical pathology consultation and report on referred slides prepared elsewhere84$6,401$75
Special stained specimen slides to examine tissue, initial procedure123$4,628$34
Pathology examination of tissue using a microscope, moderately high complexity19$3,529$80
Evaluation of fine needle aspirate93$3,402$34
Microscopic genetic analysis of tumor, manual26$2,500$52
Pathology examination of specimen during surgery, first tissue block11$1,748$60
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure14$1,613$60
Fine needle aspiration using imaging guidance21$1,573$56
Surgical pathology consultation and report on referred material requiring preparation of slides19$1,551$82
Fine needle aspiration biopsy, first growth22$1,426$62
Special stained specimen slides to identify organisms including interpretation and report28$1,013$25
Flow cytometry technique for dna or cell analysis, 16 or more markers11$916$83
Ultrasonic guidance for needle placement21$610$29
Special stained specimen slides to examine tissue including interpretation and report15$326$11
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening13$265$20
Cell examination of specimen, concentration technique12$258$20

2016: 14 services

Original Medicare services billed in 2016
Evaluation of fine needle aspirate with interpretation and report159$13,263$65
Pathology examination of tissue using a microscope, intermediate complexity188$8,343$35
Special stained specimen slides to examine tissue, each additional procedure78$7,237$25
Cell examination of specimen, selective cellular enhancement technique170$4,767$25
Surgical pathology consultation and report on referred slides prepared elsewhere52$4,088$77
Special stained specimen slides to examine tissue, initial procedure92$3,535$33
Microscopic genetic analysis of tumor, manual23$2,409$50
Evaluation of fine needle aspirate55$2,200$34
Pathology examination of tissue using a microscope, moderately high complexity15$1,874$78
Surgical pathology consultation and report on referred material requiring preparation of slides21$1,595$76
Fine needle aspiration biopsy, first growth22$1,457$61
Special stained specimen slides to identify organisms including interpretation and report26$881$25
Cell examination of specimen, concentration technique12$253$21
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening11$223$20

2015: 22 services

Original Medicare services billed in 2015
Evaluation of fine needle aspirate with interpretation and report229$17,212$64
Pathology examination of tissue using a microscope, intermediate complexity298$14,255$35
Surgical pathology consultation and report on referred slides prepared elsewhere121$9,365$77
Special stained specimen slides to examine tissue, each additional procedure101$7,455$20
Pathology examination of tissue using a microscope, moderately high complexity42$6,453$79
Cell examination of specimen, selective cellular enhancement technique211$5,929$25
Special stained specimen slides to examine tissue, initial procedure128$4,623$33
Evaluation of fine needle aspirate104$3,751$34
Fine needle aspiration biopsy, first growth51$3,398$62
Microscopic genetic analysis of tumor, manual23$2,230$50
Pathology examination of tissue using a microscope, high complexity14$2,019$135
Pathology examination of specimen during surgery, first tissue block15$1,515$58
Microscopic genetic analysis of tissue, manual, initial procedure30$1,288$43
Surgical pathology consultation and report on referred material requiring preparation of slides17$1,288$76
Special stained specimen slides to identify organisms including interpretation and report35$1,267$25
Flow cytometry technique for dna or cell analysis, 16 or more markers12$1,215$101
Fine needle aspiration using imaging guidance13$776$55
Microscopic genetic analysis of tissue, manual, each additional procedure21$604$22
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode16$439$21
Pap test15$405$25
Ultrasonic guidance for needle placement12$356$30
Special stained specimen slides to examine tissue including interpretation and report21$337$11

2014: 20 services

Original Medicare services billed in 2014
Evaluation of fine needle aspirate with interpretation and report227$17,050$62
Pathology examination of tissue using a microscope, intermediate complexity332$16,214$34
Surgical pathology consultation and report on referred slides prepared elsewhere98$8,348$75
Cell examination of specimen, selective cellular enhancement technique228$6,096$24
Pathology examination of tissue using a microscope, moderately high complexity43$6,006$76
Microscopic genetic analysis of tissue, manual, initial procedure20$3,766$57
Evaluation of fine needle aspirate101$3,576$32
Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)86$3,518$11
Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain109$3,142$28
Microscopic genetic analysis of tumor, manual32$2,789$49
Fine needle aspiration biopsy, first growth37$2,671$62
Pathology examination of tissue using a microscope, high complexity18$2,555$134
Special stained specimen slides to identify organisms including interpretation and report53$1,893$24
Pathology examination of specimen during surgery, first tissue block18$1,655$57
Genetic sequencing localization, initial procedure19$1,217$53
Fine needle aspiration using imaging guidance12$818$58
Pap test27$684$25
Cell examination of specimen, concentration technique29$620$20
Ultrasonic guidance for needle placement12$389$30
Special stained specimen slides to examine tissue including interpretation and report19$346$11

2013: 20 services

Original Medicare services billed in 2013
Pathology examination of tissue using a microscope, intermediate complexity368$19,566$33
Cell examination of specimen, selective cellular enhancement technique287$17,752$51
Evaluation of fine needle aspirate with interpretation and report236$16,855$62
Special stained specimen slides to examine tissue, initial procedure112$16,089$38
Surgical pathology consultation and report on referred slides prepared elsewhere114$10,436$72
Pathology examination of tissue using a microscope, moderately high complexity56$6,782$74
Pathology examination of tissue using a microscope, high complexity22$2,901$132
Evaluation of fine needle aspirate82$2,895$32
Fine needle aspiration biopsy, first growth42$2,860$60
Microscopic genetic analysis of tumor, manual34$2,723$45
Pathology examination of specimen during surgery, first tissue block30$2,631$56
Special stained specimen slides to identify organisms including interpretation and report57$1,830$24
Surgical pathology consultation and report on referred material requiring preparation of slides20$1,754$73
Flow cytometry technique for dna or cell analysis, 16 or more markers11$1,035$94
Pap test32$904$28
Genetic sequencing localization, initial procedure12$886$52
Cell examination of specimen, concentration technique28$679$19
Special stained specimen slides to examine tissue including interpretation and report19$276$11
Pathology examination of tissue using a microscope, moderately low complexity17$181$10
Preparation of tissue for examination by removing any calcium present11$142$11

Medicaid work

$13,459 in 2024

Medicaid paid $13,459 for 500 billed services this clinician did in 2024, up to 41 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal267$6,294
TISSUE EXAM BY PATHOLOGIST130$3,907
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT41$1,851
IMHCHEM/IMCYTCHM EA ADD ANTB32$613
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure16$480
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site14$315
Medicaid work by year
2024500641$13,459
2023433438$11,349
2022179528$3,981
2021165417$4,935
2020114323$3,172
2019142322$3,881
2018119420$3,827
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
TISSUE EXAM BY PATHOLOGIST137$4,819
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal223$4,014
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT46$1,682
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure27$834

2022

Largest Medicaid services in 2022
TISSUE EXAM BY PATHOLOGIST77$1,970
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal48$779
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT29$704
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure12$313
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site13$215

2021

Largest Medicaid services in 2021
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT44$1,902
TISSUE EXAM BY PATHOLOGIST61$1,865
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site27$599
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal33$570

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST43$1,303
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT31$1,158
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal40$711

2019

Largest Medicaid services in 2019
TISSUE EXAM BY PATHOLOGIST69$1,991
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT48$1,521
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal25$369

2018

Largest Medicaid services in 2018
TISSUE EXAM BY PATHOLOGIST65$1,743
TISSUE EXAM BY PATHOLOGIST15$1,337
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal26$514
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT13$234

Money from drug and device companies

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Cepheid · 2019Their institution$14,606

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1538212337
Licence
CA G77567California G77567: Current · expires 2027-07-31
Trained
University of California, San Francisco School of Medicine, 1992
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
CA 00G775670
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZC0500X (207ZC0500X)
Mailing address
300 Pasteur Dr Rm L235, Department of Pathology, Stanford, CA, 94305
NPI first listed
2007-01-18
NPI last updated
2024-03-14
NPI record certified
2024-03-14

This is when the NPI record was last certified, not a medical board exam.